IL91814A0 - Pharmaceutical compositions comprising pteridines,certain novel pteridines and their preparation - Google Patents
Pharmaceutical compositions comprising pteridines,certain novel pteridines and their preparationInfo
- Publication number
- IL91814A0 IL91814A0 IL91814A IL9181489A IL91814A0 IL 91814 A0 IL91814 A0 IL 91814A0 IL 91814 A IL91814 A IL 91814A IL 9181489 A IL9181489 A IL 9181489A IL 91814 A0 IL91814 A0 IL 91814A0
- Authority
- IL
- Israel
- Prior art keywords
- pteridines
- group
- preparation
- substituted
- carbon atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
- C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention relates to medicaments containing a pteridine of the formula <IMAGE> in which n is the number 0 or 1, R2 and R7 are each a pyrrolidino, piperidino or morpholino group which is optionally substituted by one or two methyl groups, R3 is a straight-chain or branched alkyl group in which one or two carbon atoms, excepting the carbon atom adjacent to the nitrogen atom, can be substituted by a hydroxyl group, R<4> is an alkyl or phenylalkyl group, in which one carbon atom, excepting the carbon atom adjacent to the nitrogen atom, can be substituted by a hydroxyl group, and R5 is a hydrogen atom or a methyl group, or the acid addition salts thereof and at least one chemotherapeutic from the natural product series, and to the use of the above pteridines for sensitisation of tumours during chemotherapy with the abovementioned chemotherapeutics, and to pteridines, process for the preparation thereof and medicaments containing these pteridines.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3833393A DE3833393A1 (en) | 1988-10-01 | 1988-10-01 | USE OF PTERIDINES TO PREVENT PRIMARY AND SECONDARY RESISTANCE IN CHEMOTHERAPY AND MEDICINES CONTAINING THESE COMPOUNDS |
Publications (2)
Publication Number | Publication Date |
---|---|
IL91814A0 true IL91814A0 (en) | 1990-06-10 |
IL91814A IL91814A (en) | 1994-02-27 |
Family
ID=6364156
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL9181489A IL91814A (en) | 1988-10-01 | 1989-09-28 | Pharmaceutical compositions comprising 6-phenyl (methyl)-2,7-bis (cyclic amino)-4- pteridinamines, certain novel such pteridines and their preparation |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0362645B1 (en) |
JP (1) | JPH02256676A (en) |
KR (1) | KR910006289A (en) |
AT (1) | ATE106728T1 (en) |
AU (1) | AU620645B2 (en) |
DD (1) | DD299062A5 (en) |
DE (2) | DE3833393A1 (en) |
DK (1) | DK480489A (en) |
ES (1) | ES2056174T3 (en) |
FI (1) | FI92699C (en) |
HU (1) | HU205761B (en) |
IL (1) | IL91814A (en) |
MX (1) | MX9203034A (en) |
NO (1) | NO175979C (en) |
NZ (1) | NZ230833A (en) |
PT (1) | PT91836B (en) |
SU (1) | SU1720491A3 (en) |
UA (1) | UA8028A1 (en) |
ZA (1) | ZA897414B (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002533464A (en) * | 1998-12-28 | 2002-10-08 | カー・イュー・ルーベン・リサーチ・アンド・ディベロップメント | Immunosuppressive effects of pteridine derivatives |
US7276506B2 (en) | 1998-12-28 | 2007-10-02 | 4 Aza Bioscience Nv | Immunosuppressive effects of pteridine derivatives |
DE10202468A1 (en) * | 2002-01-23 | 2004-09-30 | Faustus Forschungs Cie. Translational Cancer Research Gmbh | Pteridine derivatives, process for their preparation and their use |
AU2004271721A1 (en) * | 2003-09-12 | 2005-03-24 | 4 Aza Bioscience Nv | Pteridine derivatives for the treatment of septic shock and TNF-alpha-related diseases. |
AU2004283479A1 (en) * | 2003-10-17 | 2005-05-06 | 4 Aza Bioscience Nv | Heterocycle-substituted pteridine derivatives and their use in therapy |
RU2447074C2 (en) * | 2005-05-12 | 2012-04-10 | Тиботек Фармасьютикалз Лтд. | Pteridines effective as hcv inhibitors and methods for producing pteridines |
US10144736B2 (en) | 2006-07-20 | 2018-12-04 | Gilead Sciences, Inc. | Substituted pteridines useful for the treatment and prevention of viral infections |
CU20180011A7 (en) | 2015-03-04 | 2018-06-05 | Gilead Sciences Inc | PHARMACEUTICAL COMPOSITIONS THAT INCLUDE COMPOUNDS DERIVED FROM DIAMINOPIRED (3,2-D) AS TOLL TYPE RECEIVER MODULATORS |
KR20160003575A (en) | 2015-11-09 | 2016-01-11 | 정민시 | Power transmitting apparatus for generator |
WO2018045150A1 (en) | 2016-09-02 | 2018-03-08 | Gilead Sciences, Inc. | 4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators |
PL3507276T3 (en) | 2016-09-02 | 2022-02-21 | Gilead Sciences, Inc. | Toll like receptor modulator compounds |
TWI751516B (en) | 2019-04-17 | 2022-01-01 | 美商基利科學股份有限公司 | Solid forms of a toll-like receptor modulator |
TWI751517B (en) | 2019-04-17 | 2022-01-01 | 美商基利科學股份有限公司 | Solid forms of a toll-like receptor modulator |
TW202115056A (en) | 2019-06-28 | 2021-04-16 | 美商基利科學股份有限公司 | Processes for preparing toll-like receptor modulator compounds |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3574206A (en) * | 1965-04-15 | 1971-04-06 | Boehringer Sohn Ingelheim | 2,7-dimorpholino-4-amino-6-phenyl-pteridines |
NL129630C (en) * | 1966-10-14 | |||
DE1617336C2 (en) * | 1966-11-25 | 1982-07-01 | C.H. Boehringer Sohn, 6507 Ingelheim | Medicines for angina pectoris |
DE1795515A1 (en) * | 1967-08-18 | 1972-03-30 | Thomae Gmbh Dr K | Process for the production of new pteridines |
DE1795516A1 (en) * | 1967-12-15 | 1972-01-27 | Thomae Gmbh Dr K | 4-AEthanolisopropanolamino-2- (2'-methylmorpholino) -7-morpholino-6-phenyl-pteridine |
DE1921308A1 (en) * | 1969-04-25 | 1971-01-07 | Boehringer Sohn Ingelheim | Pharmaceutical prepns. containing one or more of cpds. of general formula (I):- ArOCH2 - CHOH - CH2 - NHR (I) Ar= opt. mono-or polysubstd. iso-, hom |
US4767761A (en) * | 1987-11-04 | 1988-08-30 | Dana-Farber Cancer Institute, Inc. | Ornithine derivatives and their use as methotrexate-resistant cell inhibitors |
-
1988
- 1988-10-01 DE DE3833393A patent/DE3833393A1/en not_active Withdrawn
-
1989
- 1989-09-23 ES ES89117610T patent/ES2056174T3/en not_active Expired - Lifetime
- 1989-09-23 DE DE58907824T patent/DE58907824D1/en not_active Expired - Fee Related
- 1989-09-23 EP EP89117610A patent/EP0362645B1/en not_active Expired - Lifetime
- 1989-09-23 AT AT89117610T patent/ATE106728T1/en not_active IP Right Cessation
- 1989-09-26 AU AU41749/89A patent/AU620645B2/en not_active Ceased
- 1989-09-28 PT PT91836A patent/PT91836B/en not_active IP Right Cessation
- 1989-09-28 IL IL9181489A patent/IL91814A/en not_active IP Right Cessation
- 1989-09-29 HU HU895131A patent/HU205761B/en not_active IP Right Cessation
- 1989-09-29 NZ NZ230833A patent/NZ230833A/en unknown
- 1989-09-29 DD DD89333128A patent/DD299062A5/en not_active IP Right Cessation
- 1989-09-29 UA UA4742036A patent/UA8028A1/en unknown
- 1989-09-29 NO NO893879A patent/NO175979C/en unknown
- 1989-09-29 SU SU894742036A patent/SU1720491A3/en active
- 1989-09-29 KR KR1019890014002A patent/KR910006289A/en not_active Application Discontinuation
- 1989-09-29 FI FI894615A patent/FI92699C/en not_active IP Right Cessation
- 1989-09-29 ZA ZA897414A patent/ZA897414B/en unknown
- 1989-09-29 JP JP1255126A patent/JPH02256676A/en active Pending
- 1989-09-29 DK DK480489A patent/DK480489A/en not_active Application Discontinuation
-
1992
- 1992-06-19 MX MX9203034A patent/MX9203034A/en unknown
Also Published As
Publication number | Publication date |
---|---|
MX9203034A (en) | 1992-07-01 |
IL91814A (en) | 1994-02-27 |
NO893879D0 (en) | 1989-09-29 |
ES2056174T3 (en) | 1994-10-01 |
ZA897414B (en) | 1991-06-26 |
NZ230833A (en) | 1991-05-28 |
UA8028A1 (en) | 1995-12-26 |
DK480489D0 (en) | 1989-09-29 |
DK480489A (en) | 1990-04-02 |
EP0362645A3 (en) | 1992-03-25 |
DE3833393A1 (en) | 1990-04-05 |
KR910006289A (en) | 1991-04-29 |
FI92699B (en) | 1994-09-15 |
EP0362645B1 (en) | 1994-06-08 |
HU205761B (en) | 1992-06-29 |
AU620645B2 (en) | 1992-02-20 |
FI894615A0 (en) | 1989-09-29 |
NO893879L (en) | 1990-04-02 |
DE58907824D1 (en) | 1994-07-14 |
HUT52504A (en) | 1990-07-28 |
EP0362645A2 (en) | 1990-04-11 |
AU4174989A (en) | 1990-04-05 |
DD299062A5 (en) | 1992-03-26 |
PT91836A (en) | 1990-04-30 |
NO175979B (en) | 1994-10-03 |
FI894615A (en) | 1990-04-02 |
ATE106728T1 (en) | 1994-06-15 |
JPH02256676A (en) | 1990-10-17 |
NO175979C (en) | 1995-01-11 |
FI92699C (en) | 1994-12-27 |
PT91836B (en) | 1995-07-18 |
SU1720491A3 (en) | 1992-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL91814A0 (en) | Pharmaceutical compositions comprising pteridines,certain novel pteridines and their preparation | |
NZ218786A (en) | 1,4 disubstituted piperidine derivatives and pharmaceutical compositions | |
ES8305356A1 (en) | Carbostyril derivatives and pharmaceutical composition containing the same | |
HRP940524A2 (en) | Therapeutic heterocyclic compounds | |
ES8301927A1 (en) | Substituted azobicyclooctanecarboxylic acids, process for their preparation und pharmaceutical compositions containing them. | |
ES8707238A1 (en) | Pteridines, process for their preparation, and their use as intermediates or as medicaments. | |
ES8307743A1 (en) | 3-Hydroxypyrrolidin-2-one derivatives, process and intermediates for their preparation and pharmaceutical preparations containing them. | |
ES390924A1 (en) | Esters of substituted nicotine acids | |
GB1084150A (en) | ||
ES345993A1 (en) | 2-(di - (beta-hydroxy-lower alkyl)amino)-4,7-di - (heterocyclic amino) - 6 - phenyl-pteridines | |
GB1512101A (en) | Piperazinopyrimidines process for their preparation and use | |
ES345992A1 (en) | 2,7-di-(heterocyclic amino)-4-amino-6-phenyl-pteridines | |
GB1320548A (en) | Nitrofurylaminoalkoxy-pyrimidines | |
DE3564106D1 (en) | 4-phenylaminopyridine derivatives, process of the preparation thereof and pharmaceutical compositions containing them | |
GB1262052A (en) | Dibenzofuran derivatives | |
GB1341170A (en) | Alkyl sulphonic acid esters of 1,3,2-oxazaphospha-cyclic compounds | |
ES485333A1 (en) | 5,6,7,8-Tetrahydro-4(3H)- quinazolinone derivatives useful as spasmolytics | |
GB1085922A (en) | Improvements in and relating to therapeutic compositions containing 2-amino-oxazolin-4-one derivatives, novel derivatives of this type and process for preparing same | |
MY101502A (en) | Substituted benzymidazole derivatives, process from their preparation and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RH | Patent void |